DULAGLUTIDE and VOMITING

5,413 reports of this reaction

3.6% of all DULAGLUTIDE reports

#6 most reported adverse reaction

Overview

VOMITING is the #6 most commonly reported adverse reaction for DULAGLUTIDE, manufactured by Eli Lilly and Company. There are 5,413 FDA adverse event reports linking DULAGLUTIDE to VOMITING. This represents approximately 3.6% of all 151,183 adverse event reports for this drug.

Patients taking DULAGLUTIDE who experience vomiting should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

VOMITING5,413 of 151,183 reports

VOMITING is moderately reported among DULAGLUTIDE users, representing a notable but not dominant share of adverse events.

Other Side Effects of DULAGLUTIDE

In addition to vomiting, the following adverse reactions have been reported for DULAGLUTIDE:

NAUSEA — 9,986 reports
INJECTION SITE PAIN — 9,796 reports
BLOOD GLUCOSE INCREASED — 9,762 reports
DIARRHOEA — 5,737 reports
INCORRECT DOSE ADMINISTERED — 5,444 reports
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION — 3,806 reports
DRUG INEFFECTIVE — 3,523 reports
WEIGHT DECREASED — 3,349 reports
DECREASED APPETITE — 3,153 reports
INJECTION SITE HAEMORRHAGE — 3,132 reports

Other Drugs Associated with VOMITING

The following drugs have also been linked to vomiting in FDA adverse event reports:

0XYGEN ABACAVIR SULFATE ABALOPARATIDE ABEMACICLIB ACETAMINOPHEN ACETAMINOPHEN 325 MG ACETAMINOPHEN 325MG ACETAMINOPHEN 500 MG ACETAMINOPHEN 500MG ACETAMINOPHEN AND CODEINE PHOSPHATE ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE ACETAMINOPHEN, ASPIRIN, AND CAFFEINE ACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINE ACETAMINOPHEN, CAFFEINE ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, AND PHENYLEPHRINE HYDROCHLORIDE ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL ACETAMINOPHEN, DEXTROMETHORPHAN HBR ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE, PHENYLEPHRINE HCL

Frequently Asked Questions

Does DULAGLUTIDE cause VOMITING?

VOMITING has been reported as an adverse event in 5,413 FDA reports for DULAGLUTIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is VOMITING with DULAGLUTIDE?

VOMITING accounts for approximately 3.6% of all adverse event reports for DULAGLUTIDE, making it a notable side effect.

What should I do if I experience VOMITING while taking DULAGLUTIDE?

If you experience vomiting while taking DULAGLUTIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

DULAGLUTIDE Full Profile All Drugs Causing VOMITING Eli Lilly and Company Drugs

Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.